(19)
(11) EP 1 272 662 A2

(12)

(88) Date of publication A3:
14.11.2002

(43) Date of publication:
08.01.2003 Bulletin 2003/02

(21) Application number: 00988273.9

(22) Date of filing: 21.12.2000
(51) International Patent Classification (IPC)7C12Q 1/68
(86) International application number:
PCT/US0034/935
(87) International publication number:
WO 0104/8244 (05.07.2001 Gazette 2001/27)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.12.1999 US 173268 P

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • CASEY, Warren Michael,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)
  • CHEN, Jingwen,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)
  • COLTON, Heidi M.,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)
  • TAYLOR, David,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)
  • WEINER, Michael Phillip
    Guilford, CT 06437-4334 (US)

(74) Representative: Giddings, Peter John, Dr. 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS